Waverton Investment Management’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
Waverton Investment Management's GILD Position: Q4 2025 in Review
Waverton Investment Management sold out of Gilead Sciences (GILD) in Q4 2025, closing a stake of 2,000 shares — an estimated $222K sold.
Waverton Investment Management first reported a position in GILD in Q4 2013 and held it in 21 quarters. The position peaked at $89.4M in Q2 2015. 2,225 funds tracked by Wall St. Rank hold GILD as of Q4 2025.
- Waverton Investment Management reported no remaining Gilead Sciences position as of Q4 2025 after selling out during the quarter.
- Waverton Investment Management sold 2,000 Gilead Sciences shares in Q4 2025, an estimated $222K.
- Waverton Investment Management first reported a position in Gilead Sciences in Q4 2013 and held it in 21 quarters.
- Waverton Investment Management's Gilead Sciences position peaked at $89.4M in Q2 2015.
- 2,225 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2025.
Based on Waverton Investment Management's 13F filing for Q4 2025.